Elevance Health Q1 diluted EPS $9.59 (+15.5%); raises FY2024 adj. EPS guidance to >$37.20

Elevance Health, Inc.

2024-Q1 EPS reported $9.59 revenue$42,577,000,000

Q1 operating revenue $42.3B (+0.9% YoY); diluted EPS $9.59 (+15.5%); adjusted diluted EPS $10.64 (+12.5%).
Benefit expense ratio 85.6%, improving 20 bps; operating margin 7.1% vs 6.8% YoY.
Medical membership 46.2M, down 1.9M YoY due to Medicaid attrition, partially offset by commercial growth.
Carelon revenue $12.1B (+5%); operating gain $0.8B (+10%).
FY2024 guidance raised: diluted EPS >$34.05, adjusted >$37.20; strategic partnership with CD&R for primary care.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Elevance Health, Inc. reported the quarter ended March 31, 2024 results: revenue $42.3 billion, EPS $9.59. Guidance raised.

Period: the quarter ended March 31, 2024
Revenue: $42.3 billion
EPS: $9.59
Guidance: raised
Result: reported results

Exact text from the filing

language in such filings. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 EARNINGS RELEASE ELEVANCE HEALTH REPORTS FIRST QUARTER 2024 RESULTS • 1Q 2024 operating revenue of $42.3 billion, up 0.9% from 1Q 2023 • 1Q 2024 diluted EPS 1 of $9.59, up 15.5% from 1Q 2023 and adjusted diluted EPS 2 of $10.64, up 12.5% • FY 2024 diluted EPS and adjusted diluted EPS

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

Elevance Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-099824

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.